Search by Drug Name or NDC
NDC 70710-1377-02 Succinylcholine Chloride 20 mg/mL Details
Succinylcholine Chloride 20 mg/mL
Succinylcholine Chloride is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is SUCCINYLCHOLINE CHLORIDE.
Product Information
| NDC | 70710-1377 |
|---|---|
| Product ID | 70710-1377_bd190da3-9daf-4859-a431-87c693e18e90 |
| Associated GPIs | 74100010102005 |
| GCN Sequence Number | 004676 |
| GCN Sequence Number Description | succinylcholine chloride VIAL 20 MG/ML INJECTION |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 17992 |
| HICL Sequence Number | 001948 |
| HICL Sequence Number Description | SUCCINYLCHOLINE CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Succinylcholine Chloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Succinylcholine Chloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/mL |
| Substance Name | SUCCINYLCHOLINE CHLORIDE |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209467 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1377-02 (70710137702)
| NDC Package Code | 70710-1377-2 |
|---|---|
| Billing NDC | 70710137702 |
| Package | 25 VIAL, MULTI-DOSE in 1 TRAY (70710-1377-2) / 10 mL in 1 VIAL, MULTI-DOSE (70710-1377-1) |
| Marketing Start Date | 2018-05-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |